![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/20372503-691765001-0b0b7a5a-a1d1-11e6-9041-cbc40d61c8f5-100x53.jpeg)
Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates
NEW YORK--(BUSINESS WIRE)--Aug 9, 2024-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced second quarter 2024 financial …